Medicinal Products Availability

Dáil Éireann Debate, Thursday - 1 June 2017

Thursday, 1 June 2017

Questions (171)

John Brassil

Question:

171. Deputy John Brassil asked the Minister for Health the status of the updated submission by a company (details supplied) to bring Translarna for the treatment of Duchenne muscular dystrophy here; the reason for the delay in advancing the decision by the HSE; the date for a decision to be reached; and if he will make a statement on the matter. [26359/17]

Written answers

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.